coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Northwich PCN, Cheshire West and Chester (LAD) · Health Inequalities Profile

    PCN U88623 · NHS Cheshire and Merseyside Integrated Care Board · 7 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    76,181

    Registered population

    58.8% aged 18–64

    22.5%

    Aged 65+

    ICB 19.0% · England 17.9%

    3.7%

    Ethnic minority (non-White)

    1.6% Asian · England 9.6%

    6.8%

    In IMD quintile 1

    ICB 31.9% · England 21.0%

    ~5,032

    Core20 residents (est.)

    Resident basis; registered basis ~5,575 · see page 3

    13,974

    Hypertension register

    +6.84% in 3 yrs · England +5.60%

    681

    SMI register

    18.1% of Cheshire West and Chester (LAD)'s

    1,796

    COPD register

    Reviews -11.65% in 3 yrs

    Forecast to 2030

    16,503

    Hypertension patients, 2030

    +2,529 on today

    66.8%

    QRISK ≥20% on statins, 2030

    +3.28pp over 3 yrs

    5.8%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    -16.1%
    Under-80 blood pressure control fell over three years.

    Control is 62.9% (England 67.8%) after falling 16.1% from 2023 to 2025 (England +3.2%); 80+ control is 72.9% (England 81.2%).

    1,861
    Estimated asthma patients without an annual review.

    Asthma review coverage is 63.6% (England 65.7%) and fell 14.7% over 2023 to 2025 (England +4.4%), leaving about 1,900 of 5,111 unreviewed.

    97.0%
    Vaccination and cervical screening exceed England rates.

    In Q1 2025/26, 24-month MMR1 and 6-in-1 reached 97.0% and age-5 MMR2 95.9% (target 95.0%); cervical screening (ages 25-49) is 73.3% (England 66.8%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    An older population with 22.5% aged 65 and over may shape local clinical need

    Northwich PCN serves 76,181 registered patients. The PCN has an older age profile: 22.5% (17,119 patients) are aged 65 and over, compared with 20.3% in Cheshire West and Chester (LAD), 19.0% across NHS Cheshire and Merseyside Integrated Care Board, and 17.9% in England. Census usual residents in associated areas are 96.3% White (LAD 95.3%, ICB 93.0%, England 81.1%) and 3.7% ethnic minority, including 1.6% Asian or Asian British. This older demographic may drive higher demand for chronic disease care; ethnicity figures reflect Census residents, not registered patients.

    Age profile

    0–1718.7%
    18–6458.8%
    65+22.5%

    65+: ICB 19.0%, England 17.9%

    Ethnicity

    White96.3%
    Asian1.6%
    Mixed1.3%
    Other0.4%
    Black0.4%

    Older people · falls rows are Cheshire West and Chester (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Cheshire West and Chester LA)2,1092,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)79.7%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)53.9%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Cheshire West and Chester LA)8931,0219552024/25
    Falls deaths, all ages, per 100,000 (Cheshire West and Chester LA)14.918.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Overall Core20 deprivation is low but practice rates span 16.4 pp

    Core20 share is 6.8%, though the weighted practice share is 7.3% across unconfirmed observation periods. Both sit below Cheshire West and Chester (15.7%), NHS Cheshire and Merseyside ICB (31.9%) and England (21.0%), with an average IMD decile of 6.7 (borough 6.3, ICB 5.2, England 5.5). Practice shares span 16.4 pp: Middlewich Road Surgery has the highest concentration at 16.4% (1,202 estimated patients), while Danebridge Medical Centre has the largest volume at 1,974 estimated patients (8.2%). Estimated resident Core20 population is 5,032 across 3 decile-2 LSOAs.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Middlewich Road16.4% · 1,202 patients
    Witton Street12.9% · 1,370 patients
    Watling Street11.0% · 736 patients
    Danebridge8.2% · 1,974 patients
    Firdale2.5% · 293 patients
    Weaverham0.0% · 0 patients
    Oakwood0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    681

    SMI register

    0.89% recorded prevalence

    418

    Learning disability register

    0.55% recorded prevalence

    15

    Care homes, 663 beds

    In the PCN catchment

    9.6%

    Provide unpaid care

    Cheshire West and Chester (LAD), Census 2021

    Recorded prevalence is 0.6% (418 patients) for learning disability (LAD 0.5%, ICB 0.6%, England 0.6%) and 0.9% (681 patients) for severe mental illness (LAD 1.0%, ICB 1.1%, England 1.0%). Catchment care homes comprise 15 sites (663 beds), though beds do not establish registered residents.

    Severe mental illness: physical health checks

    Severe mental illness prevalence is 0.9%. Blood pressure checks reached 79.8%, trailing England (83.4%) after falling 1.0 pp over 2023 to 2025 (England +4.4 pp). BMI checks reached 83.2% (England 82.1%). This gap could reflect recall capacity, testable by audit.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    13,974

    Hypertension register

    +6.84%

    Register growth, 3 yrs

    Cheshire West and Chester (LAD) +6.60% · England +5.60%

    −12.08pp

    BP control, under 80

    ≤140/90 · −3.42pp aged 80+

    +2,529

    More patients by 2030

    Forecast 16,503 (20.89%)

    Hypertension case-finding and control

    Hypertension prevalence is 18.3% (13,974 patients), above Cheshire West and Chester (17.0%), the ICB (16.8%) and England (15.2%). Blood pressure control for patients aged under 80 is 62.9%, trailing Cheshire West and Chester (66.3%), the ICB (66.4%) and England (67.8%), and fell 16.1% over 2023 to 2025 (England +3.2%). Recent blood pressure checks reached 85.4% (England 90.0%), and control in patients aged 80 and over is 72.9% (England 81.2%). This lower control could reflect recall capacity, testable by recall audit. Lower clinical control leaves more hypertensive patients above threshold than nationally, making recall audits and medication titration the clinical priority.

    Lipids and statins

    Patients with QRISK ≥ 20% receiving lipid lowering therapy reached 59.6%, below Cheshire West and Chester (63.8%), the ICB (63.2%) and England (63.6%). Among CKD patients, lipid lowering coverage is 66.3% (England 70.3%). Fewer high-risk patients receive lipid-lowering therapy than nationally, making primary prevention initiation the key opportunity.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026181,456£1.20£1.71£1.86£217,747
    Cardiovascular (all), 2025252,850£3.21£4.37£3.33£811,648

    In 2026, the PCN prescribed 181,456 lipid-regulating items at £1.20 per item, below Cheshire West and Chester (£1.44), the ICB (£1.71) and England (£1.86), spending £119,761 less than at England's unit cost. Lower unit expenditure than nationally provides headroom if practices expand lipid-regulating therapy to eligible high-risk patients.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −14.73%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −1.44%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 7.1% (5,111 patients) and COPD prevalence is 2.4% (1,796 patients), both above England (6.6% and 1.9%). Over 2023 to 2025, asthma reviews dropped 14.7% to 63.6% (England rose +4.4% to 65.7%), leaving about 1,900 patients unreviewed, while COPD reviews fell 11.7% to 68.0% (England rose +2.8% to 76.4%). Practice COPD prevalence spans from 2.0% at Oakwood Medical Centre to 3.1% at Middlewich Road Surgery. Declines could reflect review capacity, testable by recall audit.

    Cancer register and children's immunisation

    Cancer prevalence is 4.8% (3,646 patients), above England (3.8%). Childhood immunisation is high: age-5 MMR2 is 95.9% and 24-month MMR1 is 97.0%, both meeting the 95.0% target. However, 12-month 6-in-1 is 94.9% and age-5 4-in-1 is 94.1%. Same-cohort age-five MMR dose differences reach 12.5 pp at Watling Street Surgery and 7.1 pp at Witton Street Surgery.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months94.9%

    England 91.0%

    6-in-1 complete primary course at 24 months97.0%

    England 92.2%

    MMR dose 1 at 24 months97.0%

    England 88.3%

    MMR dose 2 at age 595.9%

    England 82.8%

    4-in-1 pre-school booster at age 594.1%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.5%

    Cheshire and Merseyside ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,640

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Cheshire and Merseyside ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%11%2,354
    Breast87.1%85.4%11%2,083
    Prostate52.3%53.2%12%2,037
    Bowel44.9%47.0%16%1,674
    Skin cancer86.9%87.8%21%932

    Across NHS Cheshire and Merseyside ICB in 2022, 55.5% of cancers with a known stage were diagnosed at stage 1 or 2 (7,482 of 13,490; England 55.3%), 19.5 pp below the 75.0% national ambition (requiring about 2,640 extra early-stage cases). Known-stage coverage was 72.8% (13,490 of 18,522; England 67.0%), describing the wider system rather than PCN performance. In primary care, PCN cervical screening coverage is 73.3% (England 66.8%), but fell 3.3% over 2023 to 2025 (England -1.0%), dropping to 66.4% at Watling Street Surgery and 67.8% at Witton Street Surgery. Screening declines at lower-coverage practices could delay early cancer detection.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    For cancer waiting times in Jul 2026 (provisional), Mid Cheshire Hospitals NHS Foundation Trust met the 75.0% faster diagnosis standard at 80.0%, compared with North Cheshire and Mersey NHS Foundation Trust (80.2%), Manchester University NHS Foundation Trust (80.1%), England (79.3%), and NHS Cheshire and Merseyside Integrated Care Board (77.2%). For the 85.0% 62-day referral to treatment standard, Mid Cheshire achieved 71.1%, trailing North Cheshire and Mersey (83.7%), the ICB (76.2%), Manchester University (72.8%), and England (71.2%). These hospital operational metrics describe secondary care pressure across the local acute system, not PCN performance.

    Pathways within standard (%)Mid CheshireNorth Cheshire and MerseyManchesterCheshire and Merseyside ICBEngland
    28-day faster diagnosis (75%)79.9580.2180.0677.2579.32
    31-day treatment (96%)86.2198.1792.5495.7192.50
    62-day referral to treatment (85%)71.1283.6772.8576.2371.16
    Diagnostic waits over 6 weeks (%)Mid CheshireNorth Cheshire and MerseyManchesterEngland
    MRI5.150.5311.6821.40
    CT1.092.3214.669.92
    Echocardiography5.5128.044.9128.48
    Colonoscopy30.3415.984.5130.83
    Gastroscopy31.8920.2429.3529.02
    All 15 DM01 tests12.726.348.9823.14
    Community services activityCheshire West and Chester residentsCheshire and Merseyside ICB
    Care contacts47,655541,280
    Referrals10,32597,150
    Patients with a contact18,585146,240

    Community services (residents of Cheshire West and Chester), Jun 2026 (provisional). In Jun 2026 (provisional), community health service contacts for Cheshire West and Chester borough residents totaled 47,655. Contacts with adults aged 65 and over accounted for 52.7% of this activity (25,095 contacts). These figures reflect local authority resident demand across wider community intermediate and rehabilitation pathways rather than PCN-level activity.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice phone contact ease spans 45.0 percentage points across Northwich PCN

    Overall QOF achievement was 88.9% at Oakwood Medical Centre, compared with 92.5% for England. Achievement was 100.0% at Firdale Medical Centre and 100.0% at The Weaverham Surgery. Vaccination and immunisation achievement spanned 45.0 pp, from 55.0% at Middlewich Road Surgery to 100.0% at Firdale Medical Centre.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Firdale1082.574.4%70.8%91.7%
    Witton Street10812.977.3%72.2%81.3%
    Weaverham1050.060.9%68.5%79.8%
    Watling Street11811.049.7%71.1%78.3%
    Middlewich Road10316.457.8%79.2%77.8%
    Danebridge1058.232.3%51.4%71.3%
    Oakwood990.046.4%71.8%65.2%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNCheshire West and Chester (LAD)AssetPCNCheshire West and Chester (LAD)
    Care homes (catchment)15 (663 beds)n/aSchools (catchment)71n/a
    Children's centres315Places of worship54231
    Libraries316Food banks (VCS)n/a1
    Homelessness support (VCS)n/a1Day centres (VCS)n/a1
    Carers support groups (VCS)n/a1Primary schools (LA maintained)1470
    Primary academies1546Special schools15

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma and COPD review recall

    Asthma reviews fell 14.7% over 2023 to 2025 to 63.6% (England +4.4% to 65.7%), leaving 1,861 (about 1,900) of 5,111 patients unreviewed; COPD reviews fell 11.7% to 68.0% (England 76.4%; 1,796 patients, 2.4%). Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Hypertension control and lipid therapy recall

    Under-80 BP control is 62.9% (England 67.8%), falling 16.1% over 2023 to 2025 (England +3.2%) across 13,974 hypertension patients (18.3%); QRISK ≥ 20% lipid therapy is 59.6% (England 63.6%). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 3

    Two-track Core20 outreach and phone audit

    Practice Core20 shares span 16.4 pp (up to 16.4%, 1,202 estimated patients; largest volume 1,974 at 8.2%), GPPS phone ease spans 45.0 pp (32.3% to 77.3%; England 56.9%), and SMI BP checks are 79.8% (England 83.4%). Low cost, quick to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Two-track Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical health recall audit (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension recall audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall outreach (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening uptake review (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)—PCN
    Primary care phone access review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Structured asthma and COPD review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · COPD registerCore20PLUS5 respiratoryPCN
    Option 2 · Hypertension control and lipid therapy recall (p12)Hypertension register · Hypertension: QOF prevalence · Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 3 · Two-track Core20 outreach and phone audit (p12)Core20 cohort (IMD quintile 1) · GPPS easy to contact the practice by phone · GPPS last request led to a booked appointmentMHIS · From Harm to HopePCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15